A Leap Forward in Cancer Vaccination
In the relentless pursuit of innovative cancer treatments, we are proud to unveil our latest breakthrough: the BREGIX™ RNA Cocktail Vaccine. This pioneering vaccine represents a beacon of hope in the fight against breast cancer, offering a new horizon for patients around the globe. After successfully completing animal trials, Phase 1 and Phase 2 Human trials, BREGIX™ is currently in Phase 3 human trials, bringing us closer to a major advancement in cancer therapy offering a new horizon for patients around the globe.
The BREGIX™ vaccine is the culmination of years of research and development, harnessing the power of RNA technology to target and combat breast cancer at its genetic roots. By meticulously designing a cocktail of RNAs, this vaccine works to modulate the expression of genes critical for the development and progression of breast cancer, providing a targeted approach to cancer immunotherapy.
Precision and Innovation at Its CoreA Vision for a Cancer-Free Future
The BREGIX™ leverages advanced biotechnological methodologies to ensure maximum efficacy and safety, setting a new standard in vaccine development.
The development of the BREGIX™ RNA Cocktail Vaccine embodies our commitment to transforming the landscape of cancer treatment. Our vision is to provide a groundbreaking solution that not only treats but potentially prevents breast cancer, reducing the global burden of this devastating disease.
The Promise of BREGIX™
- Targeted Action: By focusing on RNA, BREGIX™ offers a precise mechanism of action, targeting the molecular intricacies of breast cancer.
- Safety and Efficacy: Developed through rigorous research, our vaccine is designed to meet the highest standards of safety and effectiveness.
- Hope for Millions: BREGIX™ represents a significant step forward in making breast cancer a preventable and treatable condition, offering hope to millions of women worldwide.
Embrace the Future of Breast Cancer Treatment
The BREGIX™ RNA Cocktail Vaccine is not just a product; it's a revolution in the making. As we move forward, we remain dedicated to advancing our research, refining our approaches, and bringing innovative solutions to patients in need. Join us on this journey toward a healthier, cancer-free future. Discover the potential of BREGIX™ and how it's setting new benchmarks in the quest to conquer breast cancer.
Contact us
+44 7865 271532
info@genetixresearch.com
30, Churchill Place London, E14 5EU, United Kingdom
125 Kingsway, Aviation House, WC2B 6NH, United Kingdom
Biocity, Bo’Ness Rd, Newhouse, Motherwell, ML1 5UH, United Kingdom
© 2021 – 2025 Genetix Research Ltd. All rights reserved